In an analysis of more than 18,000 patients treated for colon cancer, current smokers were 14 percent more likely to die from their colon cancer within five years than patients who had never smoked.
In an analysis of more than 18,000 patients treated for colon cancer, current smokers were 14 percent more likely to die from their colon cancer within five years than patients who had never smoked. Among patients treated by surgery only, current smokers were 21 percent more likely to die from their colon cancer than patients who had never smoked.
“While further research is needed to elucidate mechanisms, continued efforts to encourage smoking prevention and cessation may yield benefits in terms of improved survival from colon cancer,” wrote the authors of the Alimentary Pharmacology & Therapeutics study.
Additional Information
Link to study: http://onlinelibrary.wiley.com/doi/10.1111/apt.13944/abstract
About Journal
Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology.
The journal accepts original papers and systematic reviews concerned with clinical gastroenterology, hepatology and endoscopy.
AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.
Penny Smith-
+44 (0)1243 770171
sciencenewsroom@wiley.com